Diligence memo · auto-generated · as of July 2, 2026
Origin Speech Therapy Inc.
Origin Speech Therapy Inc. looks over-valued against its niche peers and is active on financing cadence.
Businessfiled
Origin Speech Therapy Inc. operates in Other Health Care, based in SAN FRANCISCO.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
Origin Speech Therapy Inc. has raised $2.6M in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Seed (a $1.0M–$4.0M round).
Largest single filing: $2.6M on 2025-11-20.
Most recent recorded round closed around 2025-11-20.
Valuation (modeled)modeled
Provath models Origin Speech Therapy Inc. at approximately $6.4M (range $2.2M–$12M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Over-valued. Modeled value is 1.52× the median modeled value of Seed Other Health Care companies in 2025–2027 (105 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 7 mo ago; this sector typically re-raises about every 14 months.
Raising on or ahead of the sector's normal rhythm.
Comparablesmixed
Capital scale ranks ahead of 52% of Other Health Care peers (5377 compared).
Modeled value ranks above 26% of those peers.
Closest niche peers: Xymogen, Inc., Willow Life Sciences, Inc., ManyClicks, Inc., Sterile State, Inc., Limber Prosthetics, Inc..
Peoplefiled
2 named people on file across officers, directors and signatories.
Risks & flagsmixed
Modeled above niche peers — valuation risk on entry.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.